Amniocentesis in the HIV-infected pregnant woman: Is there still cause for concern in the era of combination antiretroviral therapy?
- PMID: 24421839
- PMCID: PMC3852465
- DOI: 10.1155/2013/185192
Amniocentesis in the HIV-infected pregnant woman: Is there still cause for concern in the era of combination antiretroviral therapy?
Abstract
The current standard of care in Canadian obstetrical practice is to offer pregnant women the opportunity for prenatal investigation to diagnose congenital abnormalities. Prenatal amniocentesis is Canada's most commonly practiced invasive procedure for the diagnosis of chromosomal and single gene disorders. The potential risk of intrapartum HIV transmission during amniocentesis raises several ethical concerns and limits the availability of prenatal genetic testing for HIV-positive pregnant women. Complete virological suppression with antiretroviral therapy may alleviate the risk of mother-to-child transmission during amniocentesis and increase accessibility of this important diagnostic tool in the HIV-positive population. The present report describes a case involving a 32-year-old HIV-positive pregnant woman whose plasma viral load was undetectable on antiretroviral therapy; she underwent successful prenatal amniocentesis without transmission of HIV to her infant.
La norme actuelle des soins dans la pratique obstétricale canadienne consiste à offrir aux femmes enceintes la possibilité d’une évaluation prénatale afin de diagnostiquer des anomalies congénitales. L’amniocentèse prénatale est l’intervention invasive la plus pratiquée au Canada pour diagnostiquer des troubles chromosomiques ou monogéniques. Le risque potentiel de transmission intrapartum du VIH pendant l’amniocentèse soulève plusieurs questions éthiques et limite la disponibilité des tests génétiques prénatals chez les femmes enceintes positives au VIH. La suppression virologique totale grâce à l’antirétrovirothérapie pourrait réduire le risque de transmission entre la mère et l’enfant pendant l’amniocentèse et accroître l’accessibilité à cet important outil diagnostique au sein de la population positive au VIH. Le présent rapport décrit le cas d’une femme enceinte de 32 ans positive au VIH sous antivirothérapie et dont la charge virale plasmatique n’était pas décelable. Elle a subi une amniocentèse prénatale sans transmettre le VIH à son nourrisson.
Keywords: Amniocentesis; Antiretroviral therapy; HIV; Undetectable viral load.
Similar articles
-
Amniocentesis in pregnant HIV-infected patients. Absence of mother-to-child viral transmission in a series of selected patients.Eur J Obstet Gynecol Reprod Biol. 2008 Oct;140(2):212-7. doi: 10.1016/j.ejogrb.2008.04.004. Epub 2008 Jun 27. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 18584937
-
Amniocentesis in HIV pregnant women: 16 years of experience.Infect Dis Obstet Gynecol. 2013;2013:914272. doi: 10.1155/2013/914272. Epub 2013 Jul 21. Infect Dis Obstet Gynecol. 2013. PMID: 23970821 Free PMC article.
-
HIV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women?Eur J Obstet Gynecol Reprod Biol. 2003 Jun 10;108(2):137-41. doi: 10.1016/s0301-2115(02)00405-0. Eur J Obstet Gynecol Reprod Biol. 2003. PMID: 12781400
-
Genotypic resistance tests for the management of the HIV-infected pregnant woman.Scand J Infect Dis Suppl. 2003;106:70-4. Scand J Infect Dis Suppl. 2003. PMID: 15000589 Review.
-
Prevention of perinatal HIV transmission during pregnancy.J Antimicrob Chemother. 2000 Nov;46(5):657-68. doi: 10.1093/jac/46.5.657. J Antimicrob Chemother. 2000. PMID: 11062184 Review.
References
-
- Wilson RD, Langlois S, Johnson J. Mid-trimester amniocentesis fetal loss rate. J Obstet Gynaecol Can. 2007;29:586–90. - PubMed
-
- Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French Perinatal Cohorts. Am J Obstet Gynecol. 1996;175:661–7. - PubMed
-
- Lopez M, Coll O. Chronic viral infections and invasive procedures: Risk of vertical transmission and current recommendations. Fetal Diagn Ther. 2010;28:1–8. - PubMed
-
- Dugoff L, Hobbins JC. Invasive procedures to evaluate the fetus. Clin Obstet Gynecol. 2002;45:1039–53. - PubMed
-
- Giorlandino C, Gambuzza G, D’Alessio P, Santoro ML, Gentili P, Vizzone A. Blood contamination of amniotic fluid after amniocentesis in relation to placental location. Prenat Diagn. 1996;16:180–2. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources